PATENT CLAIM ANALYSIS

Application Number: 16063185
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "551000"]

Abstract:
This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out such a neoadjuvant therapy. In particular the invention relates to a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a neoadjuvant therapy for bladder cancer in a bladder cancer patient who is scheduled for a cystectomy, the therapy comprises instilling said composition into the bladder of said patient and exposing the inside of said bladder to light.

Claim (Index 31):
The neoadjuvant therapy according to  claim 30 , wherein the aqueous buffer is a phosphate buffer.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.88
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15518864', '15895996', '13975214', '15089579', '15370393']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6916382712414211
- 35 USC 102 Novelty (BERT): 0.5018709938851601
- Combined Prediction Score: 0.672661543505795
- Mean Citation Score: 167.891056
- Max Citation Score: 172.64674
- Similarity Product: 109.64318126885772

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test